This brand name is authorized in Austria, Croatia, Cyprus, Estonia, France, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, UK.
The drug ZYPADHERA contains one active pharmaceutical ingredient (API):
1
|
UNII
X7S6Q4MHCB - OLANZAPINE PAMOATE
|
|
Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| N05AH03 | Olanzapine | N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| EE | Ravimiamet | 1391835, 1391846, 1391857 |
| ES | Centro de información online de medicamentos de la AEMPS | 08479001, 08479002, 08479003 |
| FR | Base de données publique des médicaments | 63362240, 65000788, 65023242 |
| GB | Medicines & Healthcare Products Regulatory Agency | 170379, 170386, 170391 |
| IT | Agenzia del Farmaco | 039231016, 039231028, 039231030 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1005658, 1005659, 1005660 |
| NL | Z-Index G-Standaard, PRK | 90190, 90204, 90212 |
| PL | Rejestru Produktów Leczniczych | 100206201, 100206218, 100206224 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W53870001, W53871001, W53872001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.